In a study in the US, all 18 patients with rectal cancer were completely cured by a new immunotherapy drug. Tumors were not revealed in any of the patients examined after the six-month course. Some patients have been there for two years and till now no symptoms of cancer have emerged. The results of this study, led by Dr. Luis A. Diaz Jr. of MSK Cancer Center in New York, have been published in the New England Journal of Medicine.
Scientists say that even though this study was done on 18 patients is small, its results are very encouraging. In the future, this may pave the way for accurate treatment of various types of cancer. During the study, all patients were given dostarlimab, a drug called a checkpoint inhibitor. One dose was given every third week for six months. When the test was done after the completion of the dosage, none of the patients had any symptoms of cancer. Before the study, it was believed that some patients might need chemotherapy or other medication later, but this did not happen. The cancer of all the patients included in the study was in the early stage, that is, it had not started spreading to other parts of the body.
This is how medicine works
Cancer cells can hide from the body's immune system. Due to this quality, tumors are formed in the body. This drug removes that veil from cancer cells and makes them easier for our immune system to see. After this, our immune system destroys those cancer cells. That is why this procedure is called immunotherapy.
Hope tied to a test five years ago
In 2017, the pharma company Merck under the leadership of Dr. Luis Diaz tested its checkpoint inhibitor drug pembrolizumab. During that time such patients were included, who had metastatic cancer, that is, cancer had spread to many parts of the body. After taking the drug for two years, in about half of the patients, the tumor had shrunk or stopped its spread. The cancer was gone in 10 percent of the patients. Seeing this result, Dr. Diaz thought that if the drug is used on cancer from the spread in the same organ, then what will be the result? With this thought in mind, he completed the study in collaboration with the pharma company GlaxoSmithKline.
The medical world surprised by the results of clinical trials
According to the report, the patients involved in the clinical trial were earlier undergoing painful treatments like chemotherapy, radiation, and surgery to get rid of cancer. 18 patients had joined the trial thinking that this was the next phase of their treatment. However, he was surprised to learn that now he does not need any further treatment. The results of clinical trials have taken the medical world by surprise.
Also Read: Booster Dose: DCGI Approves Corbevax as Booster Dose, Biologicals Announces
Shaheed Diwas 2023: Why is Martyr's Day celebrated on March 23? and what is its importance?
Martyr's Day is celebrated every year in India to honor the martyrs and remember their sacrifices for the country. On this day, tribute is paid to Bhagat Singh and his companion Rajguru, Sukhdev, who
'I worked for 70 hours, but I cannot force anyone to do so', Narayan Murthy's new statement.
Infosys co-founder NRN Narayana Murthy has said that no one can be forced to work for long hours. But, everyone should think about it themselves and understand its need.
America: Indian-origin Nikki Haley can contest the US presidential election, and will be seen competing with Trump
The year 2024 is going to be very special in America because in 2024 the presidential elections of America are going to be held. Donald Trump will also present his candidacy in the election. So there
PAK vs SL: Pakistan beat Sri Lanka in the first test match, Abdullah Shafiq played a historic innings
SL vs PAK 1st Test: The first Test match played between Sri Lanka and Pakistan in Galle was easily won by the visiting team Pakistan. Pakistan's team did wonders by achieving the target of 342 runs in
Bhool Bhulaiyaa 2 Box Office: 'Bhool Bhulaiyaa 2' continues to earn, Karthik Aryan's film reached so close to 150 crores in 12 days
Bhool Bhulaiyaa 2 Box Office Collection Day 12: Kartik Aaryan and Kiara Advani's film Bhool Bhulaiyaa 2 has made a big collection while performing well at the box office. The film is running at a time
Corona: Corona spreads in 11 states of the country, Maharashtra is at the highest risk; a Health expert tells what to do
The new strain of the coronavirus has so far affected 257 people, and its effect has been felt in 11 states, including the country's capital, Delhi. This has once again made health agencies active.
Axiom-4: 'Hello everyone, I am like a child...', Shubhnshu Shukla's first message from space
Indian Air Force pilot and astronaut, 39-year-old Group Captain Shubhanshu Shukla flew on the Axiom-4 mission to the International Space Station (ISS). A few hours after takeoff, he released his first
Clouds engulf Delhi-NCR, cold intensifies in Uttar Pradesh, Punjab, and Haryana, with rain alerts issued for these states today.
The cold is set to intensify in North India. The Meteorological Department has issued warnings for several parts of the country, warning of snowfall, heavy rain, and severe storms. Cyclone Montha has
Kanguva Box Office Collection: Will Surya defeat Ajay-Karthik on the first day? Will it break the records of 'Singham Again' and 'Bhool Bhulaiyaa 3'
Fans were eagerly waiting for Surya's film Kanguva. Today this wait is over. Kanguva has been released in theatres. Bobby Deol and Disha Patani will be seen in the role of villain along with Surya in
Kohli's dominance despite poor form: World's top-10 batsmen with highest run-scorers after 2020, even above Rohit-Pant
Virat Kohli, who has created panic in world cricket for the last decade with his batting, is being demanded today to be dropped from the team. From social media users to cricket stalwarts, they feel
